TWi Competitors

6610 Stock

20.20 0.25 1.22%

TWi Biotechnology competes with Otsuka Information, Interactive Digital, Siward Crystal, San Lien, and Bright Led; as well as few others. Analyzing TWi Biotechnology competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of TWi Biotechnology to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

TWi Biotechnology vs Mitake Information Correlation

Excellent diversification

The correlation between TWi Biotechnology and 8284 is -0.61 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding TWi Biotechnology and 8284 in the same portfolio, assuming nothing else is changed.

Moving against TWi Stock

0.53

2882

Cathay Financial Holding

Pair Corr

Specify up to 10 symbols:

TWi Biotechnology Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between TWi Biotechnology and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of TWi and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of TWi Biotechnology does not affect the price movement of the other competitor.

	3570	6486	2484	5493	3031	3093	6123	6275	7712	8284
3570		-0.51	0.17	-0.39	0.6	-0.27	0.67	-0.4	0.82	-0.59	3570
6486	-0.51		0.37	0.88	0.12	0.78	-0.85	0.84	-0.5	0.78	6486
2484	0.17	0.37		0.31	0.61	0.3	-0.49	0.48	0.04	0.15	2484
5493	-0.39	0.88	0.31		0.23	0.73	-0.69	0.79	-0.37	0.81	5493
3031	0.6	0.12	0.61	0.23		0.37	0.04	0.22	0.62	0.02	3031
3093	-0.27	0.78	0.3	0.73	0.37		-0.6	0.72	-0.08	0.67	3093
6123	0.67	-0.85	-0.49	-0.69	0.04	-0.6		-0.75	0.65	-0.67	6123
6275	-0.4	0.84	0.48	0.79	0.22	0.72	-0.75		-0.38	0.71	6275
7712	0.82	-0.5	0.04	-0.37	0.62	-0.08	0.65	-0.38		-0.53	7712
8284	-0.59	0.78	0.15	0.81	0.02	0.67	-0.67	0.71	-0.53		8284
	3570	6486	2484	5493	3031	3093	6123	6275	7712	8284

Please upgrade your account to get full access to Macroaxis premium features

High positive correlations

5493	+ 0.88	6486
6275	+ 0.84	6486
7712	+ 0.82	3570
8284	+ 0.81	5493
6275	+ 0.79	5493
3093	+ 0.78	6486

High negative correlations

6123	- 0.85	6486
6275	- 0.75	6123
6123	- 0.69	5493
8284	- 0.67	6123
6123	- 0.6	3093
8284	- 0.59	3570

Risk-Adjusted Indicators

There is a big difference between TWi Stock performing well and TWi Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze TWi Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
3570	1.23	(0.10)	0.00	0.66	0.00	0.00	2.39	(3.09)	10.39
6486	1.25	0.17	0.07	3.41	1.29	(1.55)	2.30	(1.76)	14.64
2484	1.93	0.43	0.17	(0.77)	1.52	(2.49)	9.79	(2.61)	15.00
5493	1.52	0.06	0.01	0.17	1.81	(1.72)	4.11	(3.01)	10.09
3031	1.45	(0.04)	0.00	(0.49)	0.00	0.00	3.85	(3.13)	11.27
3093	0.71	0.02	(0.06)	(0.03)	0.85	(0.83)	1.59	(1.54)	5.31
6123	0.59	(0.26)	0.00	6.87	0.00	0.00	1.00	(1.91)	5.05
6275	1.96	0.26	0.11	0.64	1.82	(2.53)	6.25	(2.52)	16.20
7712	2.16	(0.51)	0.00	(2.87)	0.00	0.00	3.53	(4.91)	15.00
8284	0.37	0.01	(0.10)	(0.08)	0.43	(0.47)	0.81	(0.79)	2.37

TWi Biotechnology Competitive Analysis

The better you understand TWi Biotechnology competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, TWi Biotechnology's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across TWi Biotechnology's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	6610	3570	6486	2484	5493	3031	3093	6123	6275	7712
	1.22 20.20 TWi	0.29 174.50 Otsuka	2.55 80.30 Interactive	0.83 30.45 Siward	3.71 85.60 San	3.11 20.25 Bright	1.36 26.00 Taiwan	0.11 45.20 GrandTech	2.83 51.50 Yen	4.07 87.30 7712
Market Volatility (90 Days Market Risk)	Somewhat reliable	Very steady	Very steady	Not too volatile	Very steady	Very steady	Very steady	Very steady	Very steady	Very steady
Market Performance (90 Days Performance)	Soft	Weakest	Fair	Good	Mild	Weak	Soft	Weakest	Fair	Weakest
Odds of Financial Distress (Probability Of Bankruptcy)	Unknown	Low	Low	Low	Low	Low	Low	Low	Low	Unknown
Current Valuation (Equity Enterprise Value)	Over Valued	Over Valued	Under Valued	Over Valued	Fairly Valued	Over Valued	Over Valued	Under Valued	Under Valued	Over Valued
Buy or Sell Advice (Average Analysts Consensus)	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available	Not Available
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Strong Sell	Strong Hold	Sell	Strong Sell	Strong Sell	Strong Sell	Hold	Strong Hold	Strong Sell
Current Ratio	N/A	4.07	N/A	4.4	N/A	3.7	N/A	N/A	1.53	N/A
Net Asset	N/A	N/A	2.88 B	5.9 B	4.21 B	3.67 B	1.77 B	2.77 B	3.06 B	N/A
Profit Margin	N/A	N/A	0.12	0.23	0.0623	0.12	0.18	0.0617	0.055	N/A
EBITDA	N/A	135.66 M	348.61 M	748.06 M	560.79 M	382.2 M	359.39 M	528.91 M	366.62 M	N/A
Operating Margin	N/A	N/A	0.15	0.23	0.11	0.0798	0.23	0.0839	0.0465	N/A
Current Valuation	N/A	N/A	1.92 B	5.85 B	2.09 B	1.81 B	2.94 B	2.9 B	2.54 B	N/A
Price To Book	N/A	N/A	1.95	1.47	1.5	0.95	3.36	3.02	1.51	N/A
Five Year Return	N/A	5.06	N/A	5.12	N/A	N/A	N/A	N/A	N/A	N/A
Retained Earnings	N/A	N/A	N/A	431 M	N/A	387 M	N/A	N/A	N/A	N/A
Current Asset	N/A	N/A	N/A	2.17 B	N/A	2.26 B	N/A	N/A	N/A	N/A
Beta	N/A	0.84	0.51	1.01	0.21	0.65	0.63	0.49	1.19	N/A
Number Of Employees	N/A	10	21	808	18	14	17	19	15	N/A
Shares Outstanding	N/A	N/A	39.57 M	159.42 M	41.61 M	173.2 M	145.16 M	62.46 M	69.4 M	N/A
Cash Flow From Operations	N/A	83.15 M	(16.42 M)	502.39 M	274.82 M	163.44 M	431.04 M	766.56 M	(23.08 M)	N/A
Annual Yield	N/A	N/A	0.0954	0.0407	0.0618	0.0635	0.0538	0.084	0.0766	N/A
Total Debt	N/A	39.73 M	N/A	729.28 M	40 M	168.44 M	N/A	N/A	559.09 M	N/A
Return On Equity	N/A	N/A	0.19	0.21	0.2	0.0607	0.42	0.27	0.18	N/A
Z Score	N/A	23.4	N/A	4.8	31.2	9.6	1.0	1.0	2.8	N/A
Book Value Per Share	N/A	36.06	30.47	25.17	33.01	16.73	8.18	19.82	17.77	N/A
Return On Asset	N/A	N/A	0.0681	0.0889	0.0565	0.0218	0.2	0.0861	0.0358	N/A
Current Liabilities	N/A	N/A	N/A	526 M	N/A	695 M	N/A	N/A	N/A	N/A
Total Asset	N/A	N/A	2.88 B	5.9 B	4.21 B	3.67 B	1.77 B	2.77 B	3.06 B	N/A
Debt To Equity	N/A	6.4	N/A	15.7	N/A	5.8	N/A	N/A	87.8	N/A
Last Dividend Paid	N/A	3.0	N/A	1.5	3.1	1.0	1.58	4.55	2.19	N/A
Target Price	N/A	N/A	N/A	N/A	N/A	29.0	N/A	59.53	N/A	N/A
Shares Owned By Institutions	N/A	N/A	0.15	2.52	N/A	1.15	N/A	1.08	0.45	N/A
Market Capitalization	N/A	1.55 B	2.65 B	6.03 B	2.08 B	2.7 B	4.3 B	3.81 B	1.99 B	N/A
Price To Earning	N/A	15.16	N/A	13.5	N/A	21.18	N/A	N/A	24.14	N/A
Price To Sales	N/A	N/A	1.24	1.75	0.56	1.77	1.56	0.7	0.49	N/A
Net Income	N/A	102.98 M	260.65 M	405.68 M	191.05 M	249.23 M	269.06 M	279.94 M	197.07 M	N/A
Earnings Per Share	N/A	5.97	4.82	4.91	5.51	1.05	3.14	5.25	2.64	N/A
Shares Owned By Insiders	N/A	N/A	55.27	14.05	46.6	56.31	78.09	37.12	32.7	N/A
Revenue	N/A	N/A	1.87 B	3.23 B	3.12 B	1.53 B	2.02 B	4.94 B	3.93 B	N/A
Working Capital	N/A	N/A	N/A	1.65 B	N/A	1.57 B	N/A	N/A	N/A	N/A
Cash And Equivalents	N/A	377.57 M	N/A	716.19 M	N/A	897.69 M	N/A	N/A	240.23 M	N/A
Cash Per Share	N/A	22.08	N/A	4.49	N/A	4.81	N/A	N/A	3.5	N/A
Gross Profit	N/A	N/A	848.03 M	923.42 M	545.23 M	439.57 M	692.31 M	854.97 M	695.53 M	N/A
Day Typical Price	20.23	175.33	80.97	30.1	86.7	20.47	26.17	45.1	51.97	88.83
Accumulation Distribution	8048.32	241.12	7901.63	264733.0	7878.94	20909.54	32180.78	296.69	30434.92	25991.0
Market Facilitation Index	0.0	1.0E-4	0.0	N/A	0.0	0.0	0.0	0.0	0.0	0.0
Daily Balance Of Power	(0.42)	(0.20)	(0.95)	0.2381	(1.00)	(1.00)	0.2333	(0.17)	(0.75)	(0.80)
Period Momentum Indicator	(0.25)	(0.50)	(2.10)	0.25	(3.30)	(0.65)	0.35	(0.05)	(1.50)	(3.70)
Rate Of Daily Change	0.99	1.0	0.97	1.01	0.96	0.97	1.01	1.0	0.97	0.96
Day Median Price	20.25	175.75	81.3	29.92	87.25	20.58	26.25	45.05	52.2	89.6
Price Action Indicator	(0.18)	(1.50)	(2.05)	0.65	(3.30)	(0.65)	(0.07)	0.13	(1.45)	(4.15)
Relative Strength Index	N/A	50.65	46.38	71.0	43.43	51.4	59.83	29.01	48.81	47.02
Coefficient Of Variation	2099.58	(1,646)	1035.95	738.84	1971.73	(8,586)	5851.4	(351.07)	927.33	(584.20)
Mean Deviation	2.71	1.23	1.25	1.93	1.52	1.45	0.7122	0.5949	1.96	2.16
Jensen Alpha	0.239	(0.10)	0.1715	0.4312	0.0565	(0.04)	0.0188	(0.26)	0.2634	(0.51)
Total Risk Alpha	(0.19)	(0.27)	0.0059	0.1319	(0.09)	(0.21)	(0.08)	(0.34)	0.045	(0.75)
Sortino Ratio	0.0521	N/A	0.0726	0.1724	0.014	N/A	(0.06)	N/A	0.1131	N/A
Downside Variance	6.94	N/A	2.29	3.73	3.83	N/A	0.892	N/A	4.07	N/A
Standard Deviation	4.46	1.74	1.91	3.01	2.02	2.0	0.9577	0.886	2.81	2.85
Kurtosis	11.52	4.25	8.27	4.18	0.8576	2.96	1.04	2.93	3.96	1.46
Potential Upside	5.47	2.39	2.3	9.79	4.11	3.85	1.59	0.996	6.25	3.53
Treynor Ratio	(0.36)	0.6583	3.41	(0.77)	0.1672	(0.49)	(0.03)	6.87	0.6423	(2.87)
Maximum Drawdown	24.76	10.39	14.64	15.0	10.09	11.27	5.31	5.05	16.2	15.0
Variance	19.86	3.01	3.67	9.07	4.07	4.02	0.9172	0.7849	7.9	8.11
Market Risk Adjusted Performance	(0.35)	0.6683	3.42	(0.76)	0.1772	(0.48)	(0.02)	6.88	0.6523	(2.86)
Risk Adjusted Performance	0.0434	(0.04)	0.0771	0.1071	0.0437	(0)	0.0149	(0.21)	0.0867	(0.12)
Skewness	2.86	(1.19)	1.68	1.86	0.1073	1.15	0.3726	(1.00)	1.45	0.6801
Semi Deviation	2.33	N/A	1.29	1.52	1.81	N/A	0.8524	N/A	1.82	N/A
Information Ratio	0.0308	(0.10)	0.0574	0.1105	0.0136	(0.05)	(0.06)	(0.37)	0.0812	(0.20)
Value At Risk	(3.72)	(3.09)	(1.76)	(2.61)	(3.01)	(3.13)	(1.54)	(1.91)	(2.52)	(4.91)
Expected Short fall	(4.48)	N/A	(1.55)	(2.49)	(1.72)	N/A	(0.83)	N/A	(2.53)	N/A
Downside Deviation	2.63	N/A	1.51	1.93	1.96	N/A	0.9445	N/A	2.02	N/A
Semi Variance	5.43	N/A	1.67	2.32	3.27	N/A	0.7265	N/A	3.32	N/A

TWi Biotechnology Competition Performance Charts

Five steps to successful analysis of TWi Biotechnology Competition

TWi Biotechnology's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by TWi Biotechnology in relation to its competition. TWi Biotechnology's competition analysis typically involves several steps, including:

Identifying the key players in the market: This involves identifying the major competitors of TWi Biotechnology in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact TWi Biotechnology's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to TWi Biotechnology, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your TWi Biotechnology position

In addition to having TWi Biotechnology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Municipals ETFs Thematic Idea Now

Municipals ETFs

ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Municipals ETFs theme has 132 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Municipals ETFs Theme or any other thematic opportunities.

View All Next

Launch

Additional Tools for TWi Stock Analysis

When running TWi Biotechnology's price analysis, check to measure TWi Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TWi Biotechnology is operating at the current time. Most of TWi Biotechnology's value examination focuses on studying past and present price action to predict the probability of TWi Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TWi Biotechnology's price. Additionally, you may evaluate how the addition of TWi Biotechnology to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC